On the one hand, increased expression of α-synuclein protein has been detected in Y1699C or G2019S LRRK2 PD patient iPS-derived dopamine neurons, indicating the role of α-synuclein in LRRK2 toxicity [76-78]. The gene discussed is LRRK2; the disease is Parkinson disease.